Show
Sort by
-
ARIA-Versorgungspfade für die Allergenimmuntherapie 2019 = 2019 ARIA Care pathways for allergen immunotherapy
-
- Journal Article
- A1
- open access
Guidance to 2018 good practice : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
-
ARIA 2016 executive summary : integrated care pathways for predictive, preventive and personalized medicine across the life cycle
-
Treatment of allergic rhinitis using mobile technology with real world data : the MASK observational pilot study
-
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis : a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement
-
Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study
-
- Journal Article
- A1
- open access
Work productivity in rhinitis using cell phones : the MASK pilot study
-
- Journal Article
- A1
- open access
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis : a SUNFRAIL report
-
Building bridges for innovation in ageing : synergies between action groups of the EIP on AHA
-
- Journal Article
- A1
- open access
Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies
-
- Journal Article
- A1
- open access
ARIA 2016 : care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
-
- Journal Article
- A1
- open access
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
-
- Journal Article
- A1
- open access
Allergen immunotherapy (AIT) : a prototype of precision medicine
-
MP29-02*'s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
-
Update on rupatadine in the management of allergic disorders
-
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
-
Clinical relevance is associated with allergen-specific wheal size in skin prick testing
-
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
-
Novel efficacy parameters in allergic rhinitis management : results with a new allergic rhinitis therapy (MP29-02)
-
What we should learn from the London Olympics
-
Practical guide to skin prick tests in allergy to aeroallergens
-
Severe chronic allergic (and related) diseases : a uniform approach: a MeDALL-GA²LEN-ARIA position paper
-
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs
-
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement
-
Viruses and bacteria in acute asthma exacerbations : a GA2LEN-DARE* systematic review
-
GA(2)LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma
-
Prioritised research agenda for prevention and control of chronic respiratory diseases
-
Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper
-
Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study
-
GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe
-
GA2LEN skin test study III: Minimum battery of test inhalent allergens needed in epidemiological studies in patients
-
GA2LEN skin test study I: GA superset of LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe
-
GA(2)LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'
-
ARIA update 2008: allergic rhinitis and its effect on asthma
-
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA(2)LEN paper
-
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA(2)LEN and InterAirways document
-
Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis
-
Tissue remodelling in upper airways: where is the link with lower airway remodelling?
-
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA(2)LEN)
-
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis
-
The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine
-
Characteristics of patients with seasonal allergic rhinitis and concomitant asthma
-
Requirements for medications commonly used in the treatment of allergic rhinitis
-
Requirements for medications commonly used in the treatment of allergic rhinitis - European Academy of Allergy and Clinical Immunology (EAACI) allergic rhinitis and its impact on asthma (ARIA)
-
Consensus statement on the treatment of allergic rhinitis.
-
Inhaled and nasal corticosteroids: safety aspects.
-
The impact of allergic rhinitis on quality of life and other airway diseases
-
The clinical safety of H-1-receptor antagonists : an EAACI position paper
-
The clinical safety of Hl-receptor antagonists.